2015
DOI: 10.1016/j.jocn.2015.02.016
|View full text |Cite
|
Sign up to set email alerts
|

BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(18 citation statements)
references
References 28 publications
1
17
0
Order By: Relevance
“…However, we have not shown that cells from agminated melanocytic nevi are affected with the same mutation as epidermal nevus cells, due to ethical limitations to tissue sampling. Regarding the neurologic phenotype, BRAF p.Val600Glu somatic mutations have previously been found in neocortical posterior temporal epilepsyassociated gangliogliomas or low-grade cerebral tumors, possibly with FCD type IIa (Martinoni et al, 2015;Marucci et al, 2014). The presence of the BRAF p.Lys601Asn mutation was not looked for in brain tissue, due to the absence of cerebral biopsy.…”
Section: To the Editormentioning
confidence: 99%
“…However, we have not shown that cells from agminated melanocytic nevi are affected with the same mutation as epidermal nevus cells, due to ethical limitations to tissue sampling. Regarding the neurologic phenotype, BRAF p.Val600Glu somatic mutations have previously been found in neocortical posterior temporal epilepsyassociated gangliogliomas or low-grade cerebral tumors, possibly with FCD type IIa (Martinoni et al, 2015;Marucci et al, 2014). The presence of the BRAF p.Lys601Asn mutation was not looked for in brain tissue, due to the absence of cerebral biopsy.…”
Section: To the Editormentioning
confidence: 99%
“…Differential gene expression was estimated with DESeq2 1.18.1 (RRID:SCR_015687) 97 in R 3.4.4 (RRID:SCR_001905) 98 using R Studio GUI 99 and FDR corrected pvalues (q values) of 0.05 were considered significant 100 . The results of differentially expressed genes were further analyzed for functional enrichment with DAVID 6.8 101,102 (https://david.ncifcrf.gov/home.jsp) Gene Analytics web-service (geneanalytics.genecards.org) 103 was used to analyze differentially expressed genes. Pseudorandom mouse gene list was generated in molecular biology online apps web tool (http://molbiotools.com/randomgenesetgenerator.html) using Mersenne Twister 104 pseudorandom number generator algorithm (from personal communication with Vladimír Čermák, the site developer).…”
Section: Rnaseq Gene Ontology Analysis and Gene Analyticsmentioning
confidence: 99%
“…As with FCDs, epilepsy surgery often results in seizure freedom for patients with neuroglial tumours [21][22][23][24][25][26][27]. Over the past few years, investigations have revealed possible genetic factors underlying the development of neuroglial tumours, especially that of the BRAF- [28][29][30] and PI3K-pathway [31] for gangliogliomas, and the FGFR1-pathway for DNTs [32,33]. Apart from these molecular signalling routes, distinct profiles of chromosomal copy number aberrations have also been described in neuroglial tumours [34].…”
Section: Introductionmentioning
confidence: 99%